Déficit PiSS en alpha-1 antitrypsine : un variant de risque pour le cancer du foie ? – JR 2025

Déficit PiSS en alpha-1 antitrypsine : un variant de risque pour le cancer du foie ? – JR 2025

🎙 Samuel Amintas 👥 2K 📅 November 26, 2025 ⏱ 17 min 👁 26 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

alpha-1 antitrypsinPiSS varianthepatocellular carcinomagenetic riskliver disease

Summary

This presentation from the FILFOIE research days focuses on the potential role of the PiSS variant of alpha-1 antitrypsin (AAT) as a risk factor for hepatocellular carcinoma (HCC). The speaker, Samuel Amintas, begins with an overview of AAT deficiency, a rare autosomal recessive disorder caused by mutations in the SERPINA1 gene. The most common pathogenic variants are Z and S, with Z being more severe and prevalent in Northern Europe, while S is more common in the Iberian Peninsula. The pathophysiology of the Z variant involves protein misfolding and accumulation in hepatocytes, leading to liver damage and increased risk of cirrhosis and liver cancer. The study presented aimed to estimate the prevalence of Z and S variants in a cohort of 91 patients with HCC on non-cirrhotic liver and without known risk factors. Using digital PCR, they found that 21 patients carried at least one deficient allele, with a higher proportion of MS heterozygotes than expected. Histological analysis revealed PAS-positive diastase-resistant globules in non-tumoral liver tissue of some carriers, but these were smaller and fainter than those seen in ZZ homozygotes. No globules were found in tumors. The findings suggest a potential role for the S variant in HCC risk, but larger studies with control groups are needed to confirm. The presentation concludes with a discussion on the need for further research into the pathogenic mechanisms and the importance of genotyping.

231 words

Critical Evaluation

Value of the Information & Strength of the Argument

The value of the information lies in addressing a relatively understudied variant (S) in a specific patient population (HCC on non-cirrhotic liver). The argumentation is structured logically, starting with background, then presenting methodology, results, and implications. The speaker acknowledges limitations such as small sample size and lack of control group, which strengthens the credibility. However, the evidence is preliminary and not yet peer-reviewed, so the conclusions are appropriately cautious.

Scientific Rigor, Source Quality, Title Accuracy

The presentation demonstrates scientific rigor by referencing key studies (e.g., Swedish cohort, UK Biobank) and using a robust screening method (digital PCR). The sources cited are relevant and support the background. The title accurately reflects the content, focusing on the PiSS variant and liver cancer risk. The speaker also engages in a Q&A session, addressing questions about nomenclature and geographical prevalence, which adds to the transparency. However, the lack of a control group and the small sample size limit the strength of the conclusions.

168 words

Title / Content Match

The title accurately reflects the content, focusing on the potential role of the PiSS variant in liver cancer risk.

Quality & Reliability

7/10

Presentation of original research with clear methodology, but limited sample size and lack of control group; data not yet peer-reviewed.

Key Moments

Cited Sources

  • FILFOIE website — Mentioned in the video description as the organization's official site.

Concurring Sources

  • UK Biobank — Referenced as a source for risk estimates in AAT deficiency.

Contribution & Novelties

The presentation provides new data on the prevalence of AAT variants in a specific HCC population, particularly highlighting the potential role of the S variant. It also describes histological findings of globules in heterozygotes, which is not commonly reported. The study uses a novel digital PCR method for rapid screening.

Pour aller plus loin :

83 words

Radar Profile

The radar profile shows high scores in technical level and information quality, but lower in reliability due to preliminary nature. This indicates a technically sound but not yet fully validated study.

Reliability 6/10